Cytomegalovirus Breakthrough in Pediatric Cardiac Transplant Recipients Receiving Weight-Based Dosing Valganciclovir Prophylaxis. [PDF]
Poirier N +5 more
europepmc +1 more source
Letter Regarding the Published Article "Population Pharmacokinetics and Dose Optimization of Valganciclovir and Ganciclovir in Lung Transplant Recipients". [PDF]
Sah SS, Kumbhalwar A.
europepmc +1 more source
Assessing the significance of cytomegalovirus reactivation in recipients of allogeneic hematopoietic stem cell transplantation: a cohort study. [PDF]
Oliveira LP +7 more
europepmc +1 more source
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease. [PDF]
Ellis J +10 more
europepmc +1 more source
An Uncommon Case of Disseminated Human Herpesvirus 6 Infection in an Immunocompetent Adult. [PDF]
Caetano IL +4 more
europepmc +1 more source
Anasarca Secondary to Cytomegalovirus Viremia in a Post-Liver Transplant Patient. [PDF]
Albusta N.
europepmc +1 more source
Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review. [PDF]
Karimi E +5 more
europepmc +1 more source
Secondary Prophylaxis With Bioequivalent Generic Letermovir in Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report. [PDF]
Baheti A, Bharat S.
europepmc +1 more source
Diagnosis of EBV and HCMV infections in pediatric heart transplant recipients. [PDF]
Gabeleh F +3 more
europepmc +1 more source

